We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
11 February 2020
Oviva raises USD 21M to roll out digital diabetes treatment in Europe.
The round was led by Swiss healthtech investor MTIP, joined by Earlybird as new investors. Existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech all participated. Oviva offers an evidence-based digital solution to stop the progression of reverse Type 2 diabetes and obesity-related conditions. Patients receive tailored nutrition advice and personalised coaching via their phones.
VISCHER advised the new investors in this financing round. The team was led by Dr. Matthias Staehelin (Corporate / M&A) and included Nadia Tarolli (Tax), Luzius Zumstein (Corporate / M&A), Sebastian Flückiger and Pauline Pfirter (Corporate / M&A).
Press release
Categories: Health Care, Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Startup Desk, Deals & Cases
Attorney at Law and Civil Law Notary (BS/BL)
Attorney at Law, Swiss Certified Tax Expert (2008)
Attorney at Law
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch...
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation...
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional...